EDWARD THROMBLEY: Open Payments
NPI 1558845859 · TURLOCK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,482 in 188 payments from 19 companies in 2025. Trend: 2023 $1,371 · 2024 $1,927 · 2025 $3,482
Food & beverage: $3,273Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $529 |
| Janssen Biotech, Inc. | 16 | $495 |
| Incyte Corporation | 33 | $427 |
| GENZYME CORPORATION | 10 | $315 |
| Arcutis Biotherapeutics, Inc. | 19 | $301 |
| UCB, Inc. | 22 | $292 |
| Regeneron Healthcare Solutions, Inc. | 9 | $261 |
| Galderma Laboratories, L.P. | 10 | $231 |
| Biofrontera Inc. | 24 | $195 |
| LEO Pharma Inc. | 3 | $64 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Zoryve, SKYRIZI, Bimzelx, NEMLUVIO, RINVOQ.
Industry payments across CA — which companies pay providers there.
